Abstract
According to the EUSOS study, perioperative mortality for noncardiac surgery is 1–4 % [1], considering that up to 230 million surgical procedures are performed each year in the world [2], even a small reduction would have a tremendous impact on public health.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pearse RM, Moreno RP, Bauer P et al (2012) Mortality after surgery in Europe: a 7 day cohort study. Lancet 380:1059–1065
Weiser TG, Regenbogen SE, Thompson KD et al (2008) An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 372:139–144
Landoni G, Rodseth RN, Santini F et al (2012) Randomized evidence for reduction of perioperative mortality. J Cardiothorac Vasc Anesth 26(5):764–772. pii: S1053-0770(16)30281–6. doi:10.1053/j.jvca.2016.07.017. [Epub ahead of print]
Landoni G, Pisano A, Lomivorotov V et al (2016) Randomized evidence for reduction of perioperative mortality: an updated consensus process. J Cardiothorac Vasc Anesth. 2016 Aug 2. pii: S1053-0770(16)30281-6. doi: 10.1053/j.jvca.2016.07.017. [Epub ahead of print]
Kowalewski M, Pawliszak W, Raffa GM et al (2015) Safety and efficacy of miniaturized extracorporeal circulation when compared with off-pump and conventional coronary artery bypass grafting: evidence synthesis from a comprehensive Bayesian-framework network meta-analysis of 134 randomized controlled trials involving 22 778 patients. Eur J Cardiothorac Surg 49:1428–40
Belletti A, Musu M, Silvetti S et al (2015) Non-adrenergic vasopressors in patients with or at risk for vasodilatory shock. A systematic review and meta-analysis of randomized trials. PLoS ONE 10:e0142605
Ripollés-Melchor J, Espinosa Á, Martínez-Hurtado E et al (2016) Perioperative goal-directed hemodynamic therapy in noncardiac surgery: a systematic review and meta-analysis. J Clin Anesth 28:105–115
Zangrillo A, Musu M, Greco T et al (2015) Additive effect on survival of anaesthetic cardiac protection and remote ischemic preconditioning in cardiac surgery: a Bayesian network meta-analysis of randomized trials. PLoS ONE 10:e0134264
Poirier Y, Voisine P, Plourde G et al (2016) Efficacy and safety of preoperative intra-aortic balloon pump use in patients undergoing cardiac surgery: a systematic review and meta-analysis. Int J Cardiol 207:67–79
Pilarczyk K, Boening A, Jakob H et al (2016) Preoperative intra-aortic counterpulsation in high-risk patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials. Eur J Cardiothorac Surg 49:5–17
Zhou C, Gong J, Chen D et al (2016) Levosimendan for prevention of acute kidney injury after cardiac surgery: a meta-analysis of randomized controlled trials. Am J Kidney Dis 67:408–416
Qiao L, Xu C, Li X, Li F, Liu W (2015) Heart calcium sensitizer on morbidity and mortality of high-risk surgical patients with MODS: systematic review and meta-analysis. Int J Clin Exp Med 8:17712–17720
Le Page S, Bejan-Angoulvant T, Angoulvant D, Prunier F (2015) Remote ischemic conditioning and cardioprotection: a systematic review and meta-analysis of randomized clinical trials. Basic Res Cardiol 110:11
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Summary of the New Evidences
Summary of the New Evidences
New topic | Intervention | Author | Control | Setting | N of RCT | N of patients | Size effect | Notes |
---|---|---|---|---|---|---|---|---|
Yes | Miniaturized extracorporeal circulation | Kowalewski M | Conventional extracorporeal circulation | CABG | 134 | 22,778 | OR 0.46 (95 % CI 0.22–0.91) | Network meta- analysis, comparing also off-pump CABG |
Vasopressin, terlipressin or methylene blue | Belletti A | Placebo or norepinephrine or dopamine or standard treatment | Vasodilatatory shock (cardiac surgery/critically ill (sepsis)) | 20 | 1,608 | RR 0.88 (95 % CI 0.79–0.98) | Multiple comparators Mixed population | |
Perioperative goal-directed hemodynamic therapy | Ripollés-Melchor J | Conventional fluid therapy | Noncardiac surgery | 10 | 1,527 | RR 0.63 (95 % CI 0.42–0.94) | ||
No | Volatile agents | Zangrillo A | TIVA | CCH | 55 | 6,921 | OR 0.56 (95 % CI 0.36–0.88) | Network meta-analysis (volatile, TIVA ± RIPC). Significant effect in direct comparison for volatile vs TIVA (36 studies, 3,680 patients) |
Preoperative IABP | Poirier Y | No intervention | CCH | 11 | 1,293 | OR 0.20 (95 % CI 0.09–0.44) | Observational studies were included, but were analyzed separately | |
Pilarczyk K | No intervention | CCH | 9 | 1,171 | OR 0.38 (95 % CI 0.23–0.63) | |||
Levosimendan | Zhou C | Placebo or dobutamine or milrinone | CCH | 13 | 1,254 | OR 0.43 (95 % CI 0.25–0.76) | Multiple comparators | |
Qiao L | Placebo or dobutamine or milrinone | CABG(high-risk surgical patients) | 10 | 440 | OR 0.35 (95 % CI 0.18–0.71) | Multiple comparators | ||
Remote ischemic preconditioning | Le Page S | No intervention | CCH and interventional cardiology | 44 | 5,317 | OR 0.27 (95 % CI 0.13–0.58) | Mixed population. Long -term mortality was reported only in three RCTs (383 patients) |
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Mucchetti, M., Landoni, G. (2017). Reducing Mortality in the Perioperative Period: A Continuous Update. In: Landoni, G., Ruggeri, L., Zangrillo, A. (eds) Reducing Mortality in the Perioperative Period. Springer, Cham. https://doi.org/10.1007/978-3-319-46696-5_18
Download citation
DOI: https://doi.org/10.1007/978-3-319-46696-5_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-46695-8
Online ISBN: 978-3-319-46696-5
eBook Packages: MedicineMedicine (R0)